Neovii Pharmaceuticals AG - Company & Market Research Reports

Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. It focuses on solid organ transplantation, stem cell transplantation and immune and hemato-oncological disorders. Founded in 2003, Neovii's global headquarters are located in Rapperswil, Switzerland. Its headquarters in the United States are in Waltham, MA. It employs approximately 150 people and has presence in nearly 60 countries worldwide.